This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qi, J.-S.
Right arrow Articles by Samuels, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qi, J.-S.
Right arrow Articles by Samuels, H. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 1999, p. 864-872, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Regulation of the mdm2 Oncogene by Thyroid Hormone Receptor

Jian-Shen Qi,1 Yaping Yuan,1 Vandana Desai-Yajnik,2,3 and Herbert H. Samuels1,3,*

Departments of Pharmacology,1 Pathology,2 and Medicine,3 Division of Clinical and Molecular Endocrinology, New York University Medical Center, New York, New York 10016

Received 14 May 1998/Returned for modification 30 June 1998/Accepted 21 September 1998

The mdm2 gene is positively regulated by p53 through a p53-responsive DNA element in the first intron of the mdm2 gene. mdm2 binds p53, thereby abrogating the ability of p53 to activate the mdm2 gene, and thus forming an autoregulatory loop of mdm2 gene regulation. Although the mdm2 gene is thought to act as an oncogene by blocking the activity of p53, recent studies indicate that mdm2 can act independently of p53 and block the G1 cell cycle arrest mediated by members of the retinoblastoma gene family and can activate E2F1/DP1 and the cyclin A gene promoter. In addition, factors other than p53 have recently been shown to regulate the mdm2 gene. In this article, we report that thyroid hormone (T3) receptors (T3Rs), but not the closely related members of the nuclear thyroid hormone/retinoid receptor gene family (retinoic acid receptor, vitamin D receptor, peroxisome proliferation activation receptor, or retinoid X receptor), regulate mdm2 through the same intron sequences that are modulated by p53. Chicken ovalbumin upstream promoter transcription factor I, an orphan nuclear receptor which normally acts as a transcriptional repressor, also activates mdm2 through the same intron region of the mdm2 gene. Two T3R-responsive DNA elements were identified and further mapped to sequences within each of the p53 binding sites of the mdm2 intron. A 10-amino-acid sequence in the N-terminal region of T3Ralpha that is important for transactivation and interaction with TFIIB was also found to be important for activation of the mdm2 gene response element. T3 was found to stimulate the endogenous mdm2 gene in GH4C1 cells. These cells are known to express T3Rs, and T3 is known to stimulate replication of these cells via an effect in the G1 phase of the cell cycle. Our findings, which indicate that T3Rs can regulate the mdm2 gene independently of p53, provide an explanation for certain known effects of T3 and T3Rs on cell proliferation. In addition, these findings provide further evidence for p53-independent regulation of mdm2 which could lead to the development of tumors from cells that express low levels of p53 or that express p53 mutants defective in binding to and activating the mdm2 gene.

* Corresponding author. Mailing address: Departments of Medicine and Pharmacology, TH-454, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-6279. Fax: (212) 263-7701. E-mail: samueh01{at}mcrcr.med.nyu.edu.

Molecular and Cellular Biology, January 1999, p. 864-872, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gopinathan, L., Hannon, D. B., Peters, J. M., Vanden Heuvel, J. P. (2009). Regulation of Peroxisome Proliferator-Activated Receptor-{alpha} by MDM2. Toxicol Sci 108: 48-58 [Abstract] [Full Text]  
  • Lum, S. S., Chua, H. W., Li, H., Li, W.-F., Rao, N., Wei, J., Shao, Z., Sabapathy, K. (2008). MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis 29: 754-761 [Abstract] [Full Text]  
  • Kress, E., Rezza, A., Nadjar, J., Samarut, J., Plateroti, M. (2008). The Thyroid Hormone Receptor-{alpha} (TR{alpha}) Gene Encoding TR{alpha}1 Controls Deoxyribonucleic Acid Damage-Induced Tissue Repair. Mol. Endocrinol. 22: 47-55 [Abstract] [Full Text]  
  • Mahajan, M. A., Murray, A., Levy, D., Samuels, H. H. (2007). Nuclear Receptor Coregulator (NRC): Mapping of the Dimerization Domain, Activation of p53 and STAT-2, and Identification of the Activation Domain AD2 Necessary for Nuclear Receptor Signaling. Mol. Endocrinol. 21: 1822-1834 [Abstract] [Full Text]  
  • Nelson, D. M., Bhaskaran, V., Foster, W. R., Lehman-McKeeman, L. D. (2006). p53-Independent Induction of Rat Hepatic Mdm2 following Administration of Phenobarbital and Pregnenolone 16{alpha}-Carbonitrile. Toxicol Sci 94: 272-280 [Abstract] [Full Text]  
  • Sukocheva, O A, Carpenter, D O (2006). Anti-apoptotic effects of 3,5,3'-tri-iodothyronine in mouse hepatocytes.. J Endocrinol 191: 447-458 [Abstract] [Full Text]  
  • Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., Toppmeyer, D., Offit, K., Levine, A. J. (2006). MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner.. Cancer Res. 66: 5104-5110 [Abstract] [Full Text]  
  • Li, M., Zhang, Z., Hill, D. L., Chen, X., Wang, H., Zhang, R. (2005). Genistein, a Dietary Isoflavone, Down-Regulates the MDM2 Oncogene at Both Transcriptional and Posttranslational Levels. Cancer Res. 65: 8200-8208 [Abstract] [Full Text]  
  • Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., Moore, D. D. (2005). Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor. Mol. Endocrinol. 19: 1646-1653 [Abstract] [Full Text]  
  • Shih, A., Zhang, S., Cao, H. J., Boswell, S., Wu, Y.-H., Tang, H.-Y., Lennartz, M. R., Davis, F. B., Davis, P. J., Lin, H.-Y. (2004). Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-{alpha}. Molecular Cancer Therapeutics 3: 1355-1364 [Abstract] [Full Text]  
  • Phelps, M., Darley, M., Primrose, J. N., Blaydes, J. P. (2003). p53-independent Activation of the hdm2-P2 Promoter through Multiple Transcription Factor Response Elements Results in Elevated hdm2 Expression in Estrogen Receptor {alpha}-positive Breast Cancer Cells. Cancer Res. 63: 2616-2623 [Abstract] [Full Text]  
  • Nygard, M., Wahlstrom, G. M., Gustafsson, M. V., Tokumoto, Y. M., Bondesson, M. (2003). Hormone-Dependent Repression of the E2F-1 Gene by Thyroid Hormone Receptors. Mol. Endocrinol. 17: 79-92 [Abstract] [Full Text]  
  • Wood, W. M., Sarapura, V. D., Dowding, J. M., Woodmansee, W. W., Haakinson, D. J., Gordon, D. F., Ridgway, E. C. (2002). Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor. Endocrinology 143: 347-359 [Abstract] [Full Text]  
  • Kamiya, Y., Puzianowska-Kuznicka, M., McPhie, P., Nauman, J., Cheng, S.-y., Nauman, A. (2002). Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23: 25-33 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»